Antigen specificities of HIV-infected cells: A role in infection and persistence?

被引:0
|
作者
Faua, Clayton [1 ]
Fafi-Kremer, Samira [1 ,2 ]
Gantner, Pierre [1 ,2 ,3 ]
机构
[1] Univ Strasbourg, INSERM, UMR S1109, Strasbourg, France
[2] Univ Hosp Strasbourg, Med Virol Lab, Strasbourg, France
[3] Univ Hosp Strasbourg, Med Virol Lab, 1 Rue Koeberle, F-67000 Strasbourg, France
关键词
HIV; Antigen-specificity; Productive infection; Latent infection; Memory CD4 + T cells; Persistence; CD4(+) T-CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; IN-VIVO; PERIPHERAL-BLOOD; LATENT RESERVOIR; INTACT HIV-1; EXPRESSION; REPLICATION; NEF; TRIM5-ALPHA;
D O I
10.1016/j.jve.2023.100329
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antigen-experienced memory CD4+ T cells are the major target of HIV infection and support both productive and latent infections, thus playing a key role in HIV dissemination and persistence, respectively. Here, we reviewed studies that have shown direct association between HIV infection and antigen specificity. During untreated infection, some HIV-specific cells host productive infection, while other pathogen-specific cells such as cyto-megalovirus (CMV) and Mycobacterium tuberculosis also contribute to viral persistence on antiretroviral therapy (ART). These patterns could be explained by phenotypic features differing between these pathogen-specific cells. Mechanisms involved in these preferential infection and selection processes include HIV entry and restriction, cell exhaustion, survival, self-renewal and immune escape. For instance, MIP-1 & beta; expressing cells such as CMV-specific memory cells were shown to resist infection by HIV CCR5 coreceptor downregulation/inhibition. Conversely, HIV-infected CMV-specific cells undergo clonal expansion during ART. We have identified several research areas that need further focus such as the role of other pathogens, viral genome intactness, inducibility and phenotypic features. However, given the sheer diversity of both the CD4+ T cell repertoire and antigenic history of each individual, studying HIV-infected, antigen-experienced cells still imposes numerous challenges.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiation
    Joy, Jaimy
    Gervassi, Ana
    Chen, Lennie
    Kirshenbaum, Brent
    Styrchak, Sheila
    Ko, Daisy
    McLaughlin, Sherry
    Shao, Danica
    Kosmider, Ewelina
    Edlefsen, Paul T.
    Maenza, Janine
    Collier, Ann C.
    Mullins, James I.
    Horton, Helen
    Frenkel, Lisa M.
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (14):
  • [2] Persistence of negative HIV serology in an HIV-infected child
    Schuval, SJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S211 - S211
  • [3] ANTIGEN PRESENTATION BY EPIDERMAL LANGERHANS CELLS IN HIV-INFECTED INDIVIDUALS IS NORMAL
    BLAUVELT, A
    CLERICI, M
    LUCEY, DR
    YARCHOAN, R
    WALKER, R
    SHEARER, GM
    KATZ, SI
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (04) : 543 - 543
  • [6] HCV infection and HIV-infected individuals
    Eyigun, C
    Colantoni, A
    VanThiel, DH
    JOURNAL OF HEPATOLOGY, 1997, 27 (05) : 953 - 954
  • [7] HIV-infected cells are frequently clonally expanded after prolonged antiretroviral therapy: implications for HIV persistence
    Maldarelli, Frank
    JOURNAL OF VIRUS ERADICATION, 2015, 1 (04) : 237 - 244
  • [8] In vivo persistence of donor cells following adoptive transfer of allogeneic dendritic cells in HIV-infected patients
    Shapero, MH
    Kundu, SK
    Engleman, E
    Laus, R
    van Schooten, WCA
    Merigan, TC
    CELL TRANSPLANTATION, 2000, 9 (03) : 307 - 317
  • [9] The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention
    Altice, Frederick L.
    Sullivan, Lynn E.
    Smith-Rohrberg, Duncan
    Basu, Sanjay
    Stancliff, Sharon
    Eldred, Lois
    CLINICAL INFECTIOUS DISEASES, 2006, 43 : S178 - S183
  • [10] Rhodococcus equi infection in HIV-infected patients
    Donisi, A
    Suardi, MG
    Casari, S
    Longo, M
    Cadeo, GP
    Carosi, G
    AIDS, 1996, 10 (04) : 359 - 362